These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 8530814)

  • 1. Prospective study of plasma fibronectin in fulminant hepatitis: association with infection and mortality.
    Acharya SK; Dasarathy S; Irshad M
    J Hepatol; 1995 Jul; 23(1):8-13. PubMed ID: 8530814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the molecular forms of fibronectin in fulminant hepatic failure.
    Almasio PL; Hughes RD; Williams R
    Hepatology; 1986; 6(6):1340-5. PubMed ID: 3098666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fibronectin in acute and subacute hepatic failure.
    Anand AC; Irshad M; Acharya SK; Gandhi BM; Joshi YK; Tandon BN
    J Clin Gastroenterol; 1989 Jun; 11(3):314-9. PubMed ID: 2754218
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fibronectin and complement in immunopathogenesis of acute and subacute hepatic failure.
    Irshad M; Acharya SK; Joshi YK; Tandon BN
    J Gastroenterol Hepatol; 1994; 9(4):355-60. PubMed ID: 7948818
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin and Kupffer cell function in fulminant hepatic failure.
    Imawari M; Hughes RD; Gove CD; Williams R
    Dig Dis Sci; 1985 Nov; 30(11):1028-33. PubMed ID: 4053913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma levels and hepatic mRNA expression of transforming growth factor-beta1 in patients with fulminant hepatic failure.
    Miwa Y; Harrison PM; Farzaneh F; Langley PG; Williams R; Hughes RD
    J Hepatol; 1997 Nov; 27(5):780-8. PubMed ID: 9382963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extent of the acute phase response in fulminant hepatic failure.
    Izumi S; Hughes RD; Langley PG; Pernambuco JR; Williams R
    Gut; 1994 Jul; 35(7):982-6. PubMed ID: 8063228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accurate prediction of fulminant hepatic failure in severe acute viral hepatitis: multicenter study.
    Yoshiba M; Sekiyama K; Inoue K; Yamada M; Kako M; Nagai K; Takatori M; Iwabuchi S; Sumino Y; Tanaka K; Hakozaki Y; Hasegawa K; Shibuya A
    J Gastroenterol; 2002; 37(11):916-21. PubMed ID: 12501858
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibronectin replacement in patients with fulminant hepatic failure.
    Hughes RD; Imawari M; Bihari D; Almasio PL; Langley PG; Williams R
    Eur J Clin Invest; 1986 Oct; 16(5):352-6. PubMed ID: 3100301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Removal of endotoxin and cytokines by plasma exchange in patients with acute hepatic failure.
    Iwai H; Nagaki M; Naito T; Ishiki Y; Murakami N; Sugihara J; Muto Y; Moriwaki H
    Crit Care Med; 1998 May; 26(5):873-6. PubMed ID: 9590317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functioning liver mass in uncomplicated and fulminant acute hepatitis.
    Ramsøe K; Andreasen PB; Ranek L
    Scand J Gastroenterol; 1980; 15(1):65-72. PubMed ID: 7367824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma hepatocyte growth factor and biliprotein levels and outcome in fulminant hepatic failure.
    Hughes RD; Zhang L; Tsubouchi H; Daikuhara Y; Williams R
    J Hepatol; 1994 Jan; 20(1):106-11. PubMed ID: 8201209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibronectin in fulminant hepatic failure.
    Gonzalez-Calvin J; Scully MF; Sanger Y; Fok J; Kakkar VV; Hughes RD; Gimson AE; Williams R
    Br Med J (Clin Res Ed); 1982 Oct; 285(6350):1231-2. PubMed ID: 6812819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma short-chain fatty acids in fulminant hepatic failure.
    Lai JC; Silk DB; Williams R
    Clin Chim Acta; 1977 Jul; 78(2):305-10. PubMed ID: 884861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon and cyclosporin A in the treatment of fulminant viral hepatitis.
    Yoshiba M; Sekiyama K; Inoue K; Fujita R
    J Gastroenterol; 1995 Feb; 30(1):67-73. PubMed ID: 7719417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prognostic value of alpha-foetoprotein in fulminant hepatitis (author's transl)].
    Pastore G; Lapedota E; Dentico P; Buongiorno R; Mallardi M; Angarano G; Schiraldi O
    Quad Sclavo Diagn; 1979 Mar; 15(1):14-21. PubMed ID: 94446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etiology, outcome and prognostic indicators of childhood fulminant hepatic failure in the United kingdom.
    Lee WS; McKiernan P; Kelly DA
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):575-81. PubMed ID: 15861019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Substantial hepatic necrosis is prognostic in fulminant liver failure.
    Ndekwe P; Ghabril MS; Zang Y; Mann SA; Cummings OW; Lin J
    World J Gastroenterol; 2017 Jun; 23(23):4303-4310. PubMed ID: 28694671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early prognostic markers for fatal fulminant hepatic failure cases with viral hepatitis: proton nuclear magnetic resonance spectroscopic studies of serum.
    Bala L; Mehrotra M; Mohindra S; Saxena R; Khetrapal CL
    Dig Liver Dis; 2013 Feb; 45(2):155-63. PubMed ID: 23122710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibronectin predicts the outcome of acute-on-chronic hepatitis B liver failure.
    Chen Y; Shao Z; Yin Z; Jiang Z
    Int Health; 2015 Jan; 7(1):67-72. PubMed ID: 25173344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.